Chinese drug developer Kintor raises $45m led by state-backed FTZ Fund

Chinese drug developer Kintor raises $45m led by state-backed FTZ Fund

28 October, 2019

FTZ Fund innovative drugs Kintor

Printed by Unregistered user on Fri, 05 Dec 2025 22:59:54 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

China Digest: Kintor Pharma, CalmCar, MLog, Yida Media raise funding

Chinese drug developer I-Mab Biopharma said to file for US IPO

Read more from Greater China

HongShan aims for $2.9b sale of Golden Goose to Permira by Christmas: report

Baidu’s Kunlunxin eyes Hong Kong IPO after $283m fundraising